Home /
We are excited to share that our board member, Dr. Donato Bonifazi will be presenting EPTRI’s advancements at the 2025 annual open meeting of the European network of paediatric research at the European Medicines Agency (Enpr-EMA), where he is currently a member of the...
The EOSC Symposium 2025, organised by EOSC Association, with the support of the EOSC Gravity and EOSC Focus projects, will take place in-person on 03-05 November at the Le Plaza Hotel in Brussels. The Symposium will gather policy makers, funders, researchers,...
The Pediatric Healthcare Innovation Summit (PHIS) 2025, organized by the International Society for Pediatric Innovation (iSPI), Georgia Tech, and the FDA’s Pediatric Device Consortia, will be held from Nov 05 - 06, 2025 at Science Square Labs, The historic Academy of...
The XVII Foresight Training Course will be held online on 3-4 November 2025. The training course is supported by EPTRI and organised by its member Gianni Benzi Pharmacological Research Foundation. It will focus on the current status and advancements of clinical...
The largest and most established orphan drug & rare disease meeting – The World Orphan Drug Congress – will be held on 27 – 29 October, at RAI Congress Centre in Amsterdam. EPTRI will present a poster during the Congress to showcase EPTRI Thematic Research...
We are excited to participate in the EFGCP “Better Medicines for Children” Conference, being held on October 21-22, in Amsterdam. This year's conference focuses on “Innovation in paediatric drug development as a driver for change”. The conference will bring together...
The delay in the implementation of the Life Science Strategy represents a barrier to Europe’s trial eco-system and affects the health of European citizens, particularly small populations such as paediatric and people living with orphan diseases. A report supported...
Our board member, Giovanni Migliaccio, representing EPTRI in TRANSFORM Alliance, has participated in the ATMPs: Gateway to European Global Leadership, an informal roundtable on the Pharmaceutical Package and forthcoming biotech legislation, held online on July 16th. ...
We are excited to share EPTRI’s two new members, one patient organisation and a public biomedical research organisation. Duchenne Data Foundation (DDF) works in collaboration with the World Duchenne Organization (WDO) to achieve the best possible outcomes for the...
EPTRI is strengthening its research infrastructure by applying to the “Research infrastructure services to enable R&I addressing main challenges and EU priorities related to the health domain” (HORIZON-INFRA-2025-01-SERV-01) call. EPTRI’s application to this...